AI-generated summary
This Cochrane review pooled 22 randomised trials of low-level laser therapy for carpal tunnel syndrome, involving 1153 participants. The authors report very low-quality evidence for any benefit over placebo, and found no data supporting a clear clinical effect. They also state that evidence on adverse events was insufficient.
- Participants
- 1,153
- Studies included
- 22
- Who or what was studied
- Adults with carpal tunnel syndrome enrolled in randomised controlled trials comparing low-level laser therapy with placebo or other non-surgical treatments
- Limits stated in the abstract
- The authors note that most included studies were small, had few events, high or unclear risk of bias, and imprecise, inconsistent effect estimates.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Visual analogue scale, Minimal clinically important difference, Risk of bias, Light-emitting diode, Confidence interval, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.